NSE filing, NSE: MEDISTEP. Summary written from the filing by ALFA Finder's alert engine.
Medistep Healthcare Ltd: key numbers
- Share price
- ₹18.75
- Market cap
- ₹26.64 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹5.98 Cr
- P/E (TTM)
- 4.5×Sector 48.7×
- Promoter holding
- 68.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medistep Healthcare Ltd
All →Medistep Healthcare Other Announcement
Medistep Healthcare Limited has submitted the compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.
Medistep Healthcare Board Meeting Outcome
Medistep Healthcare Limited announced the outcome of its board meeting held on August 24, 2026. Key decisions include notice for the AGM and appointment of auditors.
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited has issued a notice for its 3rd Annual General Meeting (AGM) to be held on September 17, 2026. The filing includes the company's annual report.
Medistep Healthcare Merger & Restructuring
Medistep Healthcare is incorporating a wholly owned subsidiary, Genicus Healthcare Private Limited. The new entity will manufacture nutraceuticals and allopathic products in India.
Medistep Healthcare H2 FY26 Results: Net Profit ₹3 Cr, Up 20.0% YoY
Medistep Healthcare Ltd reported revenue from operations of ₹35.8 Cr (+26.1% YoY) and net profit of ₹3 Cr (+20.0% YoY) for H2 FY26.
- Key figure
- Net profit ₹3 Cr · +20.0% YoY
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM